Antiviral research--21st international conference.
Turner
Ben
B
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. ben.turner@thomsonreuters.com
D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001117:Arenaviridae Infections / Q000188:drug therapy; D015608:Cowpox virus / Q000187:drug effects; D024882:Drug Resistance, Viral / Q000187:drug effects; D023581:HIV Fusion Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D019428:HIV Integrase Inhibitors / Q000494:pharmacology; D016174:Hepacivirus / Q000187:drug effects; D006515:Hepatitis B virus / Q000187:drug effects; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D014615:Vaccinia / Q000188:drug therapy; D014616:Vaccinia virus / Q000187:drug effects; D014780:Viruses / Q000187:drug effects* / Q000235:genetics
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D023581:HIV Fusion Inhibitors; D019428:HIV Integrase Inhibitors; D056572:Histone Deacetylase Inhibitors; D018894:Reverse Transcriptase Inhibitors